These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 1269861

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Serum lysozyme in Crohn's disease and ulcerative colitis.
    Falchuk KR, Perrotto JL, Isselbacher KJ.
    N Engl J Med; 1975 Feb 20; 292(8):395-7. PubMed ID: 1110725
    [Abstract] [Full Text] [Related]

  • 3. Indices of granulocyte activity in ulcerative colitis and Crohn's disease.
    Koldkjaer O, Klitgaard NA, Schmidt KG.
    Dan Med Bull; 1977 Apr 20; 24(2):72-6. PubMed ID: 852316
    [No Abstract] [Full Text] [Related]

  • 4. The diagnostic value of serum lysozyme activity in inflammatory bowel disease.
    Ayulo JA, Chen CC, Pelot D, Berk JE.
    Am J Gastroenterol; 1977 Jul 20; 68(1):71-6. PubMed ID: 910787
    [Abstract] [Full Text] [Related]

  • 5. Serum lysozyme in Crohn's disease and ulcerative colitis.
    Hylander E, Hansen NE, Karle H, Janrum S.
    Scand J Gastroenterol; 1976 Jul 20; 11(2):213-7. PubMed ID: 1265442
    [Abstract] [Full Text] [Related]

  • 6. Letter: Serum lysozyme levels in Crohn's disease and ulcerative colitis.
    Hylander E, Hansen NE, Karle H, Jarnum S.
    N Engl J Med; 1976 Jan 08; 294(2):111. PubMed ID: 1244493
    [No Abstract] [Full Text] [Related]

  • 7. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M, Jahnsen J, Lygren I, Stray N, Sauar J, Vatn MH, Moum B, IBSEN Study Group.
    Gut; 2008 Nov 08; 57(11):1518-23. PubMed ID: 18566104
    [Abstract] [Full Text] [Related]

  • 8. Serum lysozyme in inflammatory bowel disease.
    Dobbins JW, Binder HJ, Spiro HM, Finch SC.
    Gastroenterology; 1976 Mar 08; 70(3):469-71. PubMed ID: 1248707
    [Abstract] [Full Text] [Related]

  • 9. [The usefulness of reactive protein C in managing patients with ulcerative colitis and Crohn's disease].
    López Morante AJ, Sáez-Royuela F, Yuguero del Moral L, Martín Lorente JL, Ojeda Giménez C.
    Rev Esp Enferm Dig; 1993 Jan 08; 83(1):5-9. PubMed ID: 8452705
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic yield of capsule endoscopy in ulcerative colitis and inflammatory bowel disease of unclassified type (IBDU).
    Mehdizadeh S, Chen G, Enayati PJ, Cheng DW, Han NJ, Shaye OA, Ippoliti A, Vasiliauskas EA, Lo SK, Papadakis KA.
    Endoscopy; 2008 Jan 08; 40(1):30-5. PubMed ID: 18058654
    [Abstract] [Full Text] [Related]

  • 11. [Incidence of inflammatory bowel diseases in Bretagne (1994-1995). ABERMAD. Association Bertonne d'Etude et de Recherche des Maladies de l'Appareil Digesif].
    Pagenault M, Tron I, Alexandre JL, Cruchant E, Dabadie A, Chaperon J, Robaszkiewicz M, Bretagne JF.
    Gastroenterol Clin Biol; 1997 Jan 08; 21(6-7):483-90. PubMed ID: 9295976
    [Abstract] [Full Text] [Related]

  • 12. Identification of a prodromal period in Crohn's disease but not ulcerative colitis.
    Pimentel M, Chang M, Chow EJ, Tabibzadeh S, Kirit-Kiriak V, Targan SR, Lin HC.
    Am J Gastroenterol; 2000 Dec 08; 95(12):3458-62. PubMed ID: 11151877
    [Abstract] [Full Text] [Related]

  • 13. [Application of chosen granulocyte markers in diagnostics of Leśniowski-Crohn's disease and ulcerative colitis--preliminary research].
    Fedak D, Pawlica D, Ciećko-Michalska I, Solnica B, Mach T.
    Przegl Lek; 2010 Dec 08; 67(2):114-8. PubMed ID: 20557011
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serum lysozyme in Crohn's disease and ulcerative colitis.
    Helman CA, Novis BH, Bank S, Wormold L, Jacobs P.
    S Afr Med J; 1977 Dec 17; 52(26):1042-4. PubMed ID: 609977
    [Abstract] [Full Text] [Related]

  • 16. [Incidence of inflammatory bowel diseases in the department of Puy-de-Dôme in 1993 and 1994. EPIMICI. Epidémiologie des Maladies Inflammatoires Cryptogenetiques de l'Intestin group].
    Flamenbaum M, Zénut M, Aublet-Cuvelier B, Larpent JL, Fabre P, Abergel A, Dapoigny M, Bommelaer G.
    Gastroenterol Clin Biol; 1997 Dec 17; 21(6-7):491-6. PubMed ID: 9295977
    [Abstract] [Full Text] [Related]

  • 17. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease.
    Dotan I, Fishman S, Dgani Y, Schwartz M, Karban A, Lerner A, Weishauss O, Spector L, Shtevi A, Altstock RT, Dotan N, Halpern Z.
    Gastroenterology; 2006 Aug 17; 131(2):366-78. PubMed ID: 16890590
    [Abstract] [Full Text] [Related]

  • 18. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.
    Bernstein CN, Papineau N, Zajaczkowski J, Rawsthorne P, Okrusko G, Blanchard JF.
    Am J Gastroenterol; 2000 Mar 17; 95(3):677-83. PubMed ID: 10710056
    [Abstract] [Full Text] [Related]

  • 19. Serum lysozyme levels in inflammatory bowel disease.
    Manier JW, Roberts RC, Zais DP.
    Am J Gastroenterol; 1977 Mar 17; 67(3):245-8. PubMed ID: 868843
    [Abstract] [Full Text] [Related]

  • 20. Muramidase (lysozyme) in Crohn's disease and in ulcerative colitis.
    Pruzanski W, Marcon N, Ottaway C, Prokipchuk E.
    Am J Dig Dis; 1977 Nov 17; 22(11):995-8. PubMed ID: 920710
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.